Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'H-3 RACLOPRIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 107 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Suzuki, M; Hatano, K; Sakiyama, Y; Kawasumi, Y; Kato, T; Ito, K
      Age-related changes of dopamine D-1-like and D-2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography

      SYNAPSE
    2. Ruan, H; Lemaire, S
      Interactions of histogranin and related peptides with dopamine D2 receptorin rat brain membranes

      SYNAPSE
    3. Delforge, J; Bottlaender, M; Pappata, S; Loc'h, C; Syrota, A
      Absolute quantification by positron emission tomography of the endogenous ligand

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    4. de la Fuente-Fernandez, R; Lim, AS; Sossi, V; Holden, JE; Calne, DB; Ruth, TJ; Stoessl, AJ
      Apomorphine-induced changes in synaptic dopamine levels: Positron emissiontomography evidence for presynaptic inhibition

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    5. Stenfors, C; Ross, SB
      Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D-2 and 5-hydroxytryptamine(1A) receptors in the mouse brain in vivo

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    6. Armstrong, D; Strange, PG
      Dopamine D-2 receptor dimer formation - Evidence from ligand binding

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Colabufo, NA; Berardi, F; Calo, R; Leopoldo, M; Perrone, R; Tortorella, V
      Determination of dopamine D-4 receptor density in rat striatum using PB12 as a probe

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Ongali, B; Ase, AR; Hebert, C; Amdiss, F; Reader, TA
      Dopamine D-1 and D-2 receptors in the forebrain of Dystonia musculorum mutant mice: An autoradiographic survey in relation to dopamine contents

      SYNAPSE
    9. Dziedzicka-Wasylewska, M; Kolasiewicz, W; Rogoz, Z; Margas, W; Maj, J
      The role of dopamine D-2 receptor in the behavioral effects of imipramine - Study with the use of antisense oligonucleotides

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    10. Terasmaa, A; Finnman, UB; Owman, C; Ferre, S; Fuxe, K; Rinken, A
      Modulation of [S-35]GTP gamma S binding to Chinese hamster ovary cell membranes by D-2(short) dopamine receptors

      NEUROSCIENCE LETTERS
    11. Park, MH; Park, EH
      Synaptic concentration of dopamine in rat striatal slices in relationship to [H-3]raclopride binding to the dopamine D-2 receptor

      ARCHIVES OF PHARMACAL RESEARCH
    12. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    13. Gifford, AN; Park, MH; Kash, TL; Herman, LM; Park, EH; Gatley, SJ; Volkow, ND
      Effect of amphetamine-induced dopamine release on radiotracer binding to D-1 and D-2 receptors in rat brain striatal slices

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    14. Okubo, Y; Suhara, T; Suzuki, K; Kobayashi, K; Inoue, O; Terasaki, O; Someya, Y; Sassa, T; Sudo, Y; Matsushima, E; Iyo, M; Tateno, Y; Toru, M
      Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

      LIFE SCIENCES
    15. Wadenberg, MLG; Kapur, S; Soliman, A; Jones, C; Vaccarino, F
      Dopamine D-2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

      PSYCHOPHARMACOLOGY
    16. Ito, H; Okubo, Y; Halldin, C; Farde, L
      Mapping of central D-2 dopamine receptors in man using [C-11]raclopride: PET with anatomic standardization technique

      NEUROIMAGE
    17. Moresco, RM; Loc'h, C; Ottaviani, M; Guibert, B; Leviel, V; Maziere, M; Fazio, F; Maziere, B
      Effects of dopamine on the in vivo binding of dopamine D-2 receptor radioligands in rat striatum

      NUCLEAR MEDICINE AND BIOLOGY
    18. Goldman-Rakic, PS
      The relevance of the dopamine-D-1 receptor in the cognitive symptoms of schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    19. Sedvall, GC; Karlsson, P
      Pharmacological manipulation of D-1-dopamine receptor function in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    20. Randall, S; Hannigan, JH
      In utero alcohol and postnatal methylphenidate: Locomotion and dopamine receptors

      NEUROTOXICOLOGY AND TERATOLOGY
    21. Abi-Dargham, A; Simpson, N; Kegeles, L; Parsey, R; Hwang, DR; Anjilvel, S; Zea-Ponce, Y; Lombardo, I; Van Heertum, R; Mann, JJ; Foged, C; Halldin, C; Laruelle, M
      PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756

      SYNAPSE
    22. Kegeles, LS; Zea-Ponce, Y; Abi-Dargham, A; Rodenhiser, J; Wang, T; Weiss, R; Van Heertum, RL; Mann, JJ; Laruelle, M
      Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans

      SYNAPSE
    23. Inoue, O; Wakahara, S; Kobayashi, K; Gee, A
      Enhancement of H-3-N-methylspiperone binding but not H-3-raclopride binding in mouse striatum by MK-801: evidence that factors other than competitionby endogenous dopamine are responsible for changes in D-2 receptor bindingin vivo

      JOURNAL OF NEURAL TRANSMISSION
    24. Inoue, O; Kobayashi, K; Hosoi, R; Yamaguchi, M; Gee, A
      Discrepancies in apparent dopamine D2 receptor occupancy between H-3-raclopride and H-3-N-methylspiperone

      JOURNAL OF NEURAL TRANSMISSION
    25. Lillrank, SM; Lipska, BK; Weinberger, DR; Fredholm, BB; Fuxe, K; Ferre, S
      Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus

      NEUROCHEMISTRY INTERNATIONAL
    26. Chausmer, A; Ettenberg, A
      Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    27. Asencio, M; Delaquerriere, B; Cassels, BK; Speisky, H; Comoy, E; Protais, P
      Biochemical and behavioral effects of boldine and glaucine on dopamine systems

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    28. Matto, V; Allikmets, L
      Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test: No evidence for increased anxiety or changes in the [H-3]raclopride binding

      PHARMACOLOGY
    29. Tsukada, H; Nishiyama, S; Kakiuchi, T; Ohba, H; Sato, K; Harada, N
      Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [C-11]raclopride?: PET studies combined with microdialysis in conscious monkeys

      BRAIN RESEARCH
    30. Laruelle, M; Abi-Dargham, A; Gil, R; Kegeles, L; Innis, R
      Increased dopamine transmission in schizophrenia: Relationship to illness phases

      BIOLOGICAL PSYCHIATRY
    31. Noda-Saita, K; Matsumoto, M; Hidaka, K; Hatanaka, K; Ohmori, J; Okada, M; Yamaguchi, T
      Dopamine D4-like binding sites labeled by [H-3]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    32. Souza-Formigoni, MLO; De Lucca, EM; Hipolide, DC; Enns, SC; Oliveira, MGM; Nobrega, JN
      Sensitization to ethanol's stimulant effect is associated with region-specific increases in brain D2 receptor binding

      PSYCHOPHARMACOLOGY
    33. Laruelle, M
      Imaging dopamine transmission in schizophrenia

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    34. MATTO V; ALLIKMETS L
      APOMORPHINE-INDUCED AGGRESSIVE AND NONAGGRESSIVE RATS DIFFER IN [H-3]RACLOPRIDE-SENSITIVE D-2 RECEPTOR-BINDING CHARACTERISTICS

      Medical science research
    35. RIDD MJ; KITCHEN I; FOSBRAEY P
      THE EFFECT OF ACUTE KAINIC ACID TREATMENT ON DOPAMINE D-2 RECEPTORS IN RAT-BRAIN

      Neuroscience research
    36. Halldin, C; Foged, C; Chou, YH; Karlsson, P; Swahn, CG; Sandell, J; Sedvall, G; Farde, L
      Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D-1-dopamine receptors

      JOURNAL OF NUCLEAR MEDICINE
    37. MATSUI A; MATSUO H; TAKANAGA H; SASAKI S; MAEDA M; SAWADA Y
      PREDICTION OF CATALEPSIES INDUCED BY AMIODARONE, APRINDINE AND PROCAINE - SIMILARITY IN CONFORMATION OF DIETHYLAMINOETHYL SIDE-CHAIN

      The Journal of pharmacology and experimental therapeutics
    38. PROTAIS P; LESOURD M; COMOY E
      SIMILAR PHARMACOLOGICAL PROPERTIES OF 8-OH-DPAT AND ALNESPIRONE (S-20499) AT DOPAMINE-RECEPTORS - COMPARISON WITH BUSPIRONE

      European journal of pharmacology
    39. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
      SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO

      The American journal of psychiatry
    40. HALL H; HALLDIN C; JERNING E; OSTERLUND M; FARDE L; SEDVALL G
      AUTORADIOGRAPHIC COMPARISON OF [I-125] EPIDEPRIDE AND [I-125] NCQ-298BINDING TO HUMAN BRAIN EXTRASTRIATED DOPAMINE-RECEPTORS

      Nuclear medicine and biology
    41. LARUELLE M; DSOUZA CD; BALDWIN RM; ABIDARGHAM A; KANES SJ; FINGADO CL; SEIBYL JP; ZOGHBI SS; BOWERS MB; JATLOW P; CHARNEY DS; INNIS RB
      IMAGING D-2 RECEPTOR OCCUPANCY BY ENDOGENOUS DOPAMINE IN HUMANS

      Neuropsychopharmacology
    42. SEEMAN P; CORBETT R; VANTOL HHM
      ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS

      Neuropsychopharmacology
    43. MUKHERJEE J; YANG ZY; LEW R; BROWN T; KRONMAL S; COOPER MD; SEIDEN LS
      EVALUATION OF D-AMPHETAMINE EFFECTS ON THE BINDING OF DOPAMINE D-2 RECEPTOR RADIOLIGAND, F-18 FALLYPRIDE IN NONHUMAN-PRIMATES USING POSITRON EMISSION TOMOGRAPHY

      Synapse
    44. GINOVART N; FARDE L; HALLDIN C; SWAHN CG
      EFFECT OF RESERPINE-INDUCED DEPLETION OF SYNAPTIC DOPAMINE ON [C-11] RACLOPRIDE BINDING TO D-2-DOPAMINE RECEPTORS IN THE MONKEY BRAIN

      Synapse
    45. LARUELLE M; IYER RN; ALTIKRITI MS; ZEAPONCE Y; MALISON R; ZOGHBI SS; BALDWIN RM; KUNG HF; CHARNEY DS; HOFFER PB; INNIS RB; BRADBERRY CW
      MICRODIALYSIS AND SPECT MEASUREMENTS OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN NONHUMAN-PRIMATES

      Synapse
    46. HARTVIG P; TORSTENSON R; TEDROFF J; WATANABE Y; FASTH KJ; BJURLING P; LANGSTROM B
      AMPHETAMINE EFFECTS ON DOPAMINE RELEASE AND SYNTHESIS RATE STUDIED INTHE RHESUS-MONKEY BRAIN BY POSITRON EMISSION TOMOGRAPHY

      Journal of neural transmission
    47. MOERLEIN SM; PERLMUTTER JS; MARKHAM J; WELCH MJ
      IN-VIVO KINETICS OF [F-18] (N-METHYL)BENPERIDOL - A NOVEL PET TRACER FOR ASSESSMENT OF DOPAMINERGIC D2-LIKE RECEPTOR-BINDING

      Journal of cerebral blood flow and metabolism
    48. HUANG NN; ASE AR; HEBERT C; VANGELDER NM; READER TA
      EFFECTS OF CHRONIC NEUROLEPTIC TREATMENTS ON DOPAMINE D-1 AND D-2 RECEPTORS - HOMOGENATE BINDING AND AUTORADIOGRAPHIC STUDIES

      Neurochemistry international
    49. HARAGUCHI K; ITO K; KOTAKI H; SAWADA Y; IGA T
      PREDICTION OF DRUG-INDUCED CATALEPSY BASED ON DOPAMINE D-1, D-2, AND MUSCARINIC ACETYLCHOLINE-RECEPTOR OCCUPANCIES

      Drug metabolism and disposition
    50. LITTON JE; HALL H; BLOMQVIST G
      IMPROVED RECEPTOR ANALYSIS IN PET USING A-PRIORI INFORMATION FROM IN-VITRO BINDING ASSAYS

      Physics in medicine and biology
    51. DEAN B; PAVEY G; OPESKIN K
      [H-3] RACLOPRIDE BINDING TO BRAIN-TISSUE FROM SUBJECTS WITH SCHIZOPHRENIA - METHODOLOGICAL ASPECTS

      Neuropharmacology
    52. BREIER A; SU TP; SAUNDERS R; CARSON RE; KOLACHANA BS; DEBARTOLOMEIS A; WEINBERGER DR; WEISENFELD N; MALHOTRA AK; ECKELMAN WC; PICKAR D
      SCHIZOPHRENIA IS ASSOCIATED WITH ELEVATED AMPHETAMINE-INDUCED SYNAPTIC DOPAMINE CONCENTRATIONS - EVIDENCE FROM A NOVEL POSITRON EMISSION TOMOGRAPHY METHOD

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. FLORIJN WJ; TARAZI FI; CREESE I
      DOPAMINE-RECEPTOR SUBTYPES - DIFFERENTIAL REGULATION AFTER 8 MONTHS TREATMENT WITH ANTIPSYCHOTIC-DRUGS

      The Journal of pharmacology and experimental therapeutics
    54. UNTERWALD EM; TSUKADA H; KAKIUCHI T; KOSUGI T; NISHIYAMA S; KREEK MJ
      USE OF POSITRON-EMISSION-TOMOGRAPHY TO MEASURE THE EFFECTS OF NALMEFENE ON D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT-BRAIN

      Brain research
    55. TANG SW; HELMESTE DM; FANG H; LI M; VU R; BUNNEY W; POTKIN S; JONES EG
      DIFFERENTIAL LABELING OF DOPAMINE AND SIGMA-SITES BY [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IN POSTMORTEM HUMAN BRAINS

      Brain research
    56. MARZELLA PL; HILL C; KEKS N; SINGH R; COPOLOV D
      THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA

      Biological psychiatry
    57. MACFARLANE JG; LIST SJ; MOLDOFSKY H; FIRNAU G; CHEN JJ; SZECHTMAN H; GARNETT S; NAHMIAS C
      DOPAMINE D2 RECEPTORS QUANTIFIED IN-VIVO IN HUMAN NARCOLEPSY

      Biological psychiatry
    58. LAHTI RA; ROBERTS RC; CONLEY RR; COCHRANE EV; MUTIN A; TAMMINGA CA
      D-2-TYPE DOPAMINE-RECEPTORS IN POSTMORTEM HUMAN BRAIN SECTIONS FROM NORMAL AND SCHIZOPHRENIC SUBJECTS

      NeuroReport
    59. ERICSON H; RADESATER AC; SERVIN E; MAGNUSSON O; MOHRINGE B
      EFFECTS OF INTERMITTENT AND CONTINUOUS SUBCHRONIC ADMINISTRATION OF RACLOPRIDE ON MOTOR-ACTIVITY, DOPAMINE TURNOVER AND RECEPTOR OCCUPANCY IN THE RAT

      Pharmacology & toxicology
    60. HALL H; FARDE L; HALLDIN C; HURD YL; PAULI S; SEDVALL G
      AUTORADIOGRAPHIC LOCALIZATION OF EXTRASTRIATAL D-2-DOPAMINE RECEPTORSIN THE HUMAN BRAIN USING [I-125] EPIDEPRIDE

      Synapse
    61. DELFORGE J; SYROTA A; BENDRIEM B
      CONCEPT OF REACTION VOLUME IN THE IN-VIVO LIGAND-RECEPTOR MODEL

      The Journal of nuclear medicine
    62. BACHUS SE; KLEINMAN JE
      THE NEUROPATHOLOGY OF SCHIZOPHRENIA

      The Journal of clinical psychiatry
    63. KEHOE P; CLASH K; SKIPSEY K; SHOEMAKER WJ
      BRAIN DOPAMINE RESPONSE IN ISOLATED 10-DAY-OLD RATS - ASSESSMENT USING D-2 BINDING AND DOPAMINE TURNOVER

      Pharmacology, biochemistry and behavior
    64. LARUELLE M; ABIDARGHAM A; VANDYCK CH; GIL R; DSOUZA CD; ERDOS J; MCCANCE E; ROSENBLATT W; FINGADO C; ZOGHBI SS; BALDWIN RM; SEIBYL JP; KRYSTAL JH; CHARNEY DS; INNIS RB
      SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY IMAGING OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. PATEL S; PATEL S; MARWOOD R; EMMS F; MARSTON D; LEESON PD; CURTIS NR; KULAGOWSKI JJ; FREEDMAN SB
      IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF [I-125] L-750,667, A NOVEL RADIOLIGAND FOR THE DOPAMINE D-4 RECEPTOR

      Molecular pharmacology
    66. MUKHERJEE J; YANG ZY; BROWN T; ROEMER J; COOPER M
      F-18 DESMETHOXYFALLYPRIDE - A F-18 LABELED RADIOTRACER WITH PROPERTIES SIMILAR TO C-11 RACLOPRIDE FOR PET IMAGING STUDIES OF DOPAMINE D-2 RECEPTORS

      Life sciences
    67. SEEMAN P; VANTOL HHM
      DOPAMINE D4 RECEPTORS IN SCHIZOPHRENIA - REPLY

      Journal of neurochemistry
    68. FISHER RE; MORRIS ED; ALPERT NM; FISCHMAN AJ
      IN-VIVO IMAGING OF NEUROMODULATORY SYNAPTIC TRANSMISSION USING PET - A REVIEW OF RELEVANT NEUROPHYSIOLOGY

      Human brain mapping
    69. MOERLEIN SM; PERLMUTTER JS; WELCH MJ
      SPECIFIC, REVERSIBLE BINDING OF [F-18] BENPERIDOL TO BABOON D-2 RECEPTORS - PET EVALUATION OF AN IMPROVED F-18 LABELED LIGAND

      Nuclear medicine and biology
    70. LAHTI RA; ROBERTS RC; TAMMINGA CA
      D-2-FAMILY RECEPTOR DISTRIBUTION IN HUMAN POSTMORTEM TISSUE - AN AUTORADIOGRAPHIC STUDY

      NeuroReport
    71. HALL H; HALLDIN C; NYBERG S; FARDE L; SEDVALL G
      EFFECT OF CLOZAPINE AND RISPERIDONE ON 5-HT2 AND D-2-DOPAMINE RECEPTOR-BINDING IN THE POSTMORTEM HUMAN BRAIN - AN AUTORADIOGRAPHIC STUDY

      European neuropsychopharmacology
    72. FARDE L; HALL H; PAULI S; HALLDIN C
      VARIABILITY IN D-2-DOPAMINE RECEPTOR DENSITY AND AFFINITY - A PET STUDY WITH [C-11] RACLOPRIDE IN MAN

      Synapse
    73. MACH RH; EHRENKAUFER RLE; GREENBERG JH; SHAO LX; MORTON TE; EVORA PH; NOWAK PA; LUEDTKE RR; COHEN D; REIVICH M
      PET IMAGING STUDIES OF DOPAMINE D-2 RECEPTORS - COMPARISON OF [F-18] N-METHYLSPIPERONE AND THE BENZAMIDE ANALOGS [F-18]MABN AND [F-18] MBP IN BABOON BRAIN

      Synapse
    74. LIDOW MS
      D-1-DOPAMINERGIC AND D-2-DOPAMINERGIC RECEPTORS IN THE DEVELOPING CEREBRAL-CORTEX OF MACAQUE MONKEY - A FILM AUTORADIOGRAPHIC STUDY

      Neuroscience
    75. KOBASASHI K; INOUE O; WATANABE Y; ONOE H; LANGSTROM B
      DIFFERENCE IN RESPONSE OF D-2 RECEPTOR-BINDING BETWEEN C-11 N-METHYLSPIPERONE AND C-11 RACLOPRIDE AGAINST ANESTHETICS IN RHESUS-MONKEY BRAIN

      Journal of neural transmission
    76. HILLEFORSBERGLUND M; LIU Y; VONEULER G
      PERSISTENT, SPECIFIC AND DOSE-DEPENDENT EFFECTS OF TOLUENE EXPOSURE ON DOPAMINE D-2 AGONIST BINDING IN THE RAT CAUDATE-PUTAMEN

      Toxicology
    77. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ROSENBLATT W; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; CHARNEY DS; HOFFER PB; KUNG HF; INNIS RB
      SPECT IMAGING OF STRIATAL DOPAMINE RELEASE AFTER AMPHETAMINE CHALLENGE

      The Journal of nuclear medicine
    78. RAYPORT S; SULZER D
      VISUALIZATION OF ANTIPSYCHOTIC DRUG-BINDING TO LIVING MESOLIMBIC NEURONS REVEALS D2 RECEPTOR, ACIDOTROPIC, AND LIPOPHILIC COMPONENTS

      Journal of neurochemistry
    79. WALLACE DR; BOOZE RM
      IDENTIFICATION OF D-3 AND SIGMA-RECEPTORS IN THE RAT STRIATUM AND NUCLEUS-ACCUMBENS USING (+ -)-7-HYDROXY-N,N-DI-N-[H-3] PROPYL-2-AMINOTETRALIN AND CARBETAPENTANE/

      Journal of neurochemistry
    80. SUMIYOSHI T; STOCKMEIER CA; OVERHOLSER JC; THOMPSON PA; MELTZER HY
      DOPAMINE D-4 RECEPTORS AND EFFECTS OF GUANINE-NUCLEOTIDES ON [H-3] RACLOPRIDE BINDING IN POSTMORTEM CAUDATE-NUCLEUS OF SUBJECTS WITH SCHIZOPHRENIA OR MAJOR DEPRESSION

      Brain research
    81. ALTIKRITI MS; BALDWIN RM; ZEAPONCE Y; SYBIRSKA E; ZOGHBI SS; LARUELLE M; MALISON RT; KUNG HF; KESSLER RM; CHARNEY DS; HOFFER PB; INNIS RB
      COMPARISON OF 3 HIGH-AFFINITY SPECT RADIOTRACERS FOR THE DOPAMINE-D-2RECEPTOR

      Nuclear medicine and biology
    82. HALL H; SEDVALL G; MAGNUSSON O; KOPP J; HALLDIN C; FARDE L
      DISTRIBUTION OF D-1-DOPAMINE AND D-2-DOPAMINE RECEPTORS, AND DOPAMINEAND ITS METABOLITES IN THE HUMAN BRAIN

      Neuropsychopharmacology
    83. NOBREGA JN; SEEMAN P
      DOPAMINE D2 RECEPTORS MAPPED IN RAT-BRAIN WITH [H-3] (+)PHNO

      Synapse
    84. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; SCHLYER D; HITZEMANN R; LIEBERMAN J; ANGRIST B; PAPPAS N; MACGREGOR R; BURR G; COOPER T; WOLF AP
      IMAGING ENDOGENOUS DOPAMINE COMPETITION WITH [C-11] RACLOPRIDE IN THEHUMAN BRAIN

      Synapse
    85. OGREN SO; ROSEN L; FUXE K
      DOPAMINE D-2, ANTAGONIST REMOXIPRIDE ACTS IN-VIVO ON A SUBPOPULATION OF DOPAMINE D-2, RECEPTORS

      Neuroscience
    86. LOGAN J; VOLKOW ND; FOWLER JS; WANG GJ; DEWEY SL; MACGREGOR R; SCHLYER D; GATLEY SJ; PAPPAS N; KING P; HITZEMANN R; VITKUN S
      EFFECTS OF BLOOD-FLOW ON [C-11] RACLOPRIDE BINDING IN THE BRAIN - MODEL SIMULATIONS AND KINETIC-ANALYSIS OF PET DATA

      Journal of cerebral blood flow and metabolism
    87. CARLI M; ANANDSRIVASTAVA MB; MOLINAHOLGADO E; DEWAR KM; READER TA
      EFFECTS OF CHRONIC LITHIUM TREATMENTS ON CENTRAL DOPAMINERGIC RECEPTOR SYSTEMS - G-PROTEINS AS POSSIBLE TARGETS

      Neurochemistry international
    88. LARUELLE M; VANDYCK C; ABIDARGHAM A; ZEAPONCE Y; ZOGHBI SS; CHARNEY DS; BALDWIN RM; HOFFER PB; KUNG HF; INNIS RB
      COMPARTMENTAL MODELING OF IODINE-123-IODOBENZOFURAN BINDING TO DOPAMINE D2 RECEPTORS IN HEALTHY-SUBJECTS

      The Journal of nuclear medicine
    89. LIDOW MS; GOLDMANRAKIC PS
      A COMMON ACTION OF CLOZAPINE, HALOPERIDOL, AND REMOXIPRIDE ON D-1-DOPAMINERGIC AND D-2-DOPAMINERGIC RECEPTORS IN THE PRIMATE CEREBRAL-CORTEX

      Proceedings of the National Academy of Sciences of the United Statesof America
    90. SAWAGUCHI T; GOLDMANRAKIC PS
      THE ROLE OF D1-DOPAMINE RECEPTOR IN WORKING-MEMORY - LOCAL INJECTIONSOF DOPAMINE ANTAGONISTS INTO THE PREFRONTAL CORTEX OF RHESUS-MONKEYS PERFORMING AN OCULOMOTOR DELAYED-RESPONSE TASK

      Journal of neurophysiology
    91. PROTAIS P; CHAGRAOUI A; ARBAOUI J; MOCAER E
      DOPAMINE-RECEPTOR ANTAGONIST PROPERTIES OF S-14506, 8-OH-DPAT, RACLOPRIDE AND CLOZAPINE IN RODENTS

      European journal of pharmacology
    92. PILOWSKY LS; COSTA DC; ELL PJ; VERHOEFF NPLG; MURRAY RM; KERWIN RW
      D-2 DOPAMINE-RECEPTOR BINDING IN THE BASAL GANGLIA OF ANTIPSYCHOTIC-FREE SCHIZOPHRENIC-PATIENTS - AN I-123 IBZM SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY STUDY

      British Journal of Psychiatry
    93. HIETALA J; SYVALAHTI E; VUORIO K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; RAKKOLAINEN V; LEHTINEN V; WEGELIUS U
      STRIATAL D-2, DOPAMINE-RECEPTOR CHARACTERISTICS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS STUDIED WITH POSITRON EMISSION TOMOGRAPHY

      Archives of general psychiatry
    94. HIETALA J; WEST C; SYVALAHTI E; NAGREN K; LEHIKOINEN P; SONNINEN P; RUOTSALAINEN U
      STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE

      Psychopharmacology
    95. SUHARA T; INOUE O; KOBAYASHI K; SATOH T; TATENO Y
      AN ACUTE EFFECT OF TRIAZOLAM ON MUSCARINIC CHOLINERGIC RECEPTOR-BINDING IN THE HUMAN BRAIN MEASURED BY POSITRON EMISSION TOMOGRAPHY

      Psychopharmacology
    96. KESSLER RM; VOTAW JR; DEPAULIS T; BINGHAM DR; ANSARI MS; MASON NS; HOLBURN G; SCHMIDT DE; VOTAW DB; MANNING RG; EBERT MH
      EVALUATION OF 5-[F-18]FLUOROPROPYLEPIDEPRIDE AS A POTENTIAL PET RADIOLIGAND FOR IMAGING DOPAMINE D2 RECEPTORS

      Synapse
    97. SEEMAN P; GUAN HC; VANTOL HHM; NIZNIK HB
      LOW-DENSITY OF DOPAMINE D4 RECEPTORS IN PARKINSONS, SCHIZOPHRENIA, AND CONTROL BRAIN STRIATA

      Synapse
    98. SEEMAN P; ULPIAN C; LARSEN RD; ANDERSON PS
      DOPAMINE-RECEPTORS LABELED BY PHNO

      Synapse
    99. ALBURGES ME; NARANG N; WAMSLEY JK
      ALTERATIONS IN THE DOPAMINERGIC RECEPTOR SYSTEM AFTER CHRONIC ADMINISTRATION OF COCAINE

      Synapse
    100. ICHISE M; TOYAMA H; FORNAZZARI L; BALLINGER JR; KIRSH JC
      IODINE-123-IBZM DOPAMINE-D2 RECEPTOR AND TECHNETIUM-99M-HMPAO BRAIN PERFUSION SPECT IN THE EVALUATION OF PATIENTS WITH AND SUBJECTS AT RISKFOR HUNTINGTONS-DISEASE

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 09:50:54